Title : AR-V7 and prostate cancer: The watershed for treatment selection?

Pub. Date : 2016 Feb

PMID : 26827690






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Despite the recent progress in targeting persistent AR activity with the next-generation hormonal therapies (abiraterone acetate and enzalutamide), resistance to these agents limits therapeutic efficacy for many patients. Abiraterone Acetate androgen receptor Homo sapiens